← Back
Data updated: Jun 28, 2026
YAOPHARMA CO LTD
Generics Pharmaceuticals
YAOPHARMA CO LTD is a generic drug manufacturer with 4 FDA-approved products.
2015
Since
4
Drugs
-
Trials
1
New Drugs (2yr)
YAOPHARMA CO LTD's Key Drugs
YAOPHARMA CO LTD's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
YAOPHARMA CO LTD's Recent FDA Approvals
YAOPHARMA CO LTD secured 1 new FDA approval for novel drugs (NDA/BLA) in the last two years.
YAOPHARMA CO LTD's Therapeutic Areas
Disease areas where YAOPHARMA CO LTD has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
YAOPHARMA CO LTD Pipeline Snapshot
Active clinical trials for YAOPHARMA CO LTD across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2015-05-28
- Latest
- 2026-06-09
- Applications
- 4